Olanzapina Ratiopharm (Olanzapine)

Olanzapine, the active ingredient in Olanzapina Ratiopharm, is an atypical antipsychotic presented as a tablet for oral use. It is used to manage symptoms of schizophrenia and bipolar disorder in adults and adolescents. GNH USA supplies Olanzapina Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olanzapina Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Olanzapina Ratiopharm is an atypical antipsychotic that acts on psychotic and mood disorders.

- Schizophrenia: helps reduce hallucinations, delusions and thought disorder. - Bipolar I disorder (manic episodes): assists in controlling elevated mood, agitation and rapid speech. - Maintenance therapy for schizophrenia or bipolar disorder: supports long‑term symptom stability and relapse prevention.

Olanzapina Ratiopharm may cause a range of adverse reactions.

Common Side Effects: - Weight gain - Sedation - Dry mouth - Constipation - Increased appetite - Dizziness

Serious or Rare Side Effects: - Neuroleptic malignant syndrome - Tardive dyskinesia - Severe hyperglycaemia - Agranulocytosis - Seizures - Elevated blood pressure.

When using Olanzapina Ratiopharm, several precautions should be observed.

- Monitor: regular blood glucose and lipid monitoring due to metabolic risk. - Assess: baseline and periodic assessment of movement disorders. - Caution: use in patients with cardiovascular‑c​   - Caution   a   t  t \n- Caution  \

The   t